Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial
published in: Blood
date of publication: 2013-07-16
language: English
main subject: phase II clinical trial, stem cell transplantation, rituximab
Cites articles 45
Date
Title
Article - wd:Q37113099